Radiation Oncology-Biology Integration Network (ROBIN) Centers (U54 Clinical Trial Required)
Grant Opportunity Analysis
The National Cancer Institute at the National Institutes of Health is seeking cooperative agreement applications to continue the Radiation Oncology-Biology Integration Network (ROBIN) centers, a national research infrastructure focused on the biological basis of cancer responses to radiation therapy. The program supports multidisciplinary, longitudinal studies that collect and analyze biospecimens and multimodal data before, during, and after standard-of-care radiation treatment to better understand response, resistance, toxicity, and opportunities for combining radiation with other therapies. The work emphasizes integration across biology, clinical oncology, imaging, dosimetry, omics, biospecimen science, and data science, and the opportunity is designated as U54 with clinical trial required. The estimated synopsis post date is August 19, 2026, the estimated application close date is January 25, 2027, and questions may be directed by email to ROBIN_RFA@nih.gov.
Eligible Applicants
Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).
Grant Documents
No documents available for this grant.